It was found that patients suffering from breast cancer with a mutant TP53 gene had lower expression of the AMHRII gene (Fig. 7), which indirectly suggests that AMHRII may be a link in the downstream pathway after TP53 mutation. This evidence concerns the gene TP53 and breast cancer.